Menu

Blog

Archive for the ‘biotech/medical’ category: Page 2531

Jul 11, 2016

Germs add ripples to make ‘groovy’ graphene

Posted by in categories: biotech/medical, computing, engineering, nanotechnology, particle physics

Graphene, a two-dimensional wonder-material composed of a single layer of carbon atoms linked in a hexagonal chicken-wire pattern, has attracted intense interest for its phenomenal ability to conduct electricity. Now University of Illinois at Chicago researchers have used rod-shaped bacteria — precisely aligned in an electric field, then vacuum-shrunk under a graphene sheet — to introduce nanoscale ripples in the material, causing it to conduct electrons differently in perpendicular directions.

The resulting material, sort of a graphene nano-corduroy, can be applied to a silicon chip and may add to graphene’s almost limitless potential in electronics and nanotechnology. The finding is reported in the journal ACS Nano.

“The current across the graphene wrinkles is less than the current along them,” says Vikas Berry, associate professor and interim head of chemical engineering at UIC, who led the research.

Read more

Jul 11, 2016

Pomegranate finally reveals its powerful anti-aging secret

Posted by in categories: biotech/medical, health, life extension

Are pomegranates really the superfood we’ve been led to believe will counteract the aging process? Up to now, scientific proof has been fairly weak. And some controversial marketing tactics have led to skepticism as well. A team of scientists from EPFL and the company Amazentis wanted to explore the issue by taking a closer look at the secrets of this plump pink fruit. They discovered that a molecule in pomegranates, transformed by microbes in the gut, enables muscle cells to protect themselves against one of the major causes of aging. In nematodes and rodents, the effect is nothing short of amazing. Human clinical trials are currently underway, but these initial findings have already been published in the journal Nature Medicine.

As we age, our cells increasingly struggle to recycle their powerhouses. Called mitochondria, these inner compartments are no longer able to carry out their vital function, thus accumulate in the cell. This degradation affects the health of many tissues, including muscles, which gradually weaken over the years. A buildup of dysfunctional mitochondria is also suspected of playing a role in other diseases of aging, such as Parkinson’s disease.

One molecule plays David against the Goliath of aging

Continue reading “Pomegranate finally reveals its powerful anti-aging secret” »

Jul 11, 2016

This startup wants to replace the silicon in your smartphone with diamonds

Posted by in categories: 3D printing, biotech/medical, mobile phones

Synthetic diamonds and the manufacturing of diamonds in mass quantity (including 3D Printing) is going to explode over the next few years with QC, Medical devices and technologies, smartphones, etc. Again, I hope Intel, Nvidia, HP, Xerox, etc. are listening.


Chicago-based startup Akhan Semiconducton wants to replace the silicon found in most modern-day electronics with diamonds derived from methane gas.

Continue reading “This startup wants to replace the silicon in your smartphone with diamonds” »

Jul 11, 2016

Engineered human colon model could aid in cancer research

Posted by in category: biotech/medical

Cornell researchers have helped develop a recellularized human colon model that could be used to track the pathogenesis of colon cancer and possibly gain insight into its spread to other organs.

Read more

Jul 11, 2016

FDA study using genetically engineered cells to treat cancer kills three people

Posted by in categories: bioengineering, biotech/medical, genetics, neuroscience

(NaturalNews) Earlier this month, Juno Therapeutics, a pioneer in the field of treating cancer using genetically engineered cells, had to halt the development of its lead treatment after the death of three leukemia patients enrolled in the study.

The Seattle-based biotech company reported that the deaths of all three patients, who were in their 20s, were linked to swelling in the brain. The swelling occurred after the company added a second chemotherapy drug to the treatment procedure.

The news of the patient deaths is a big blow for the biotech startup that is developing a new experimental therapy known as chimeric antigen receptor T-cell (or CART) immunotherapy. The setback will likely delay the company’s aim of introducing it to the market by 2017, Juno executives said in a conference.

Continue reading “FDA study using genetically engineered cells to treat cancer kills three people” »

Jul 11, 2016

Research suggests common blood cancer could be prevented before it develops

Posted by in category: biotech/medical

They discovered that changes in the bone marrow needed for the cancer to grow have already taken hold in the preceding condition, raising the possibility that early medical intervention could prevent this incurable type of cancer from taking root.

The research, which was funded by the blood cancer charity Bloodwise, is published in the journal Leukemia.

Myeloma affects the plasma cells, a type of white blood cell that originates in the bone marrow. Diagnosed in over 4,000 people a year in the UK, fewer than half of patients survive for longer than five years after diagnosis. Symptoms often include debilitating and painful bone damage, anemia and nausea.

Read more

Jul 11, 2016

Biodiversity, GMOs, Gene Drives and the Militarized Mind

Posted by in categories: biotech/medical, existential risks

Nice callout of the Gates Foundation.


“Amaranth, Amaranto, love-lies-bleeding, tassel flower, Joseph’s coat, or ramdana (gods own grain) is the grain of well-being,” Shiva writes. (Photo: Elizabeth Weller/flickr/cc)

A recent report from the National Academy of Science of The United States, titled “Gene Drives on the Horizon: Advancing Science, Navigating Uncertainty, and Aligning Research with Public Values,” warns:

Continue reading “Biodiversity, GMOs, Gene Drives and the Militarized Mind” »

Jul 11, 2016

Mussels inspire scientists to attach biologically active molecule to titanium surface

Posted by in categories: biotech/medical, materials

Very cool; another example where nature inspires others. Einstein was inspired often by nature and its environment.


Titanium is used medically in applications such as artificial joints and dental implants. While it is strong and is not harmful to tissues, the metal lacks some of the beneficial biological properties of natural tissues such as bones and natural teeth. Now, based on insights from mussels—which are able to attach themselves very tightly to even metallic surfaces due to special proteins found in their byssal threads—scientists from RIKEN have successfully attached a biologically active molecule to a titanium surface, paving the way for implants that can be more biologically beneficial.

The work began from earlier discoveries that mussels can attach to smooth surfaces so effectively thanks to a protein, L-DOPA, which is known to be able to bind very strongly to smooth surfaces such as rocks, ceramics, or metals. Interestingly, the same protein functions in humans as a precursor to dopamine, and is used as a treatment for Parkinson’s disease.

Continue reading “Mussels inspire scientists to attach biologically active molecule to titanium surface” »

Jul 11, 2016

Nano-tech: How your DNA can enhance the power of computing

Posted by in categories: biotech/medical, computing, nanotechnology

I am glad others are seeing the light.


It holds the key to the future of bio-technology and computing.

Read more

Jul 11, 2016

BRCA mutations linked to prostate and uterine cancers

Posted by in categories: biotech/medical, genetics

Personally; I have heard this several years ago from some medical researchers. Glad that more have concluded this tie.


Genetic mutations on several genes including BRCA2 have been associated with prostate cancer; while in a separate study, a BRCA1 mutation has been linked to a particular form of uterine cancer.

The first study, published in the New England Journal of Medicine, found that 12 percent of men with advanced prostate cancer had inherited mutations in genes involved in the repair of damaged DNA.

Professor Johann de Bono of the Institute of Cancer Research in London and the Royal Marsden NHS Foundation Trust, who led the study, said: ‘Our study has shown that a significant proportion of men with advanced prostate cancer are born with DNA repair mutations – and this could have important implications for patients.

Read more